We found that the deletion of STAT1 in Mi/MΦ resulted in less brain inflammation at the subacute stage after ischemic stroke, manifested by less infiltration of blood-borne immune cells and reduced content of cytokines in the post-stroke brain. This evidence concerns the gene STAT1 and stroke disorder.